telehealth glp-1 crackdown news today FEDS CRACK DOWN ON COMPANIES SELLING GLP-1s: The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight FDA Targets Telehealth Compounded GLP-1

Collectively, these differences in chemical composition, analytical reporting, and clinical endpoints make it difficult to harmonize data across trials or perform rigorous meta-analyses

Finally, in a cohort of female hospital workers, rapid rotating NS was linked to increased serum release of stress-related steroids-corticosterone, 11-deoxycortisol, DHEA, and androstenedione, whereas estradiol levels were slightly decreased, and salivary estradiol remained unchanged, suggesting a complex and multifaceted influence of NSW on estrogen regulation 188

A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats

The findings highlight the wider economic impact of effective obesity treatment